Lyophilised haemostat platelet derivatives (Cellphire)
N/A
Report date: 2022/11/02 20:00:41
Base Information
Drug NameLyophilised haemostat platelet derivatives (Cellphire)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellphire Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesCellphire Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications +[5]
Other Information
ATC CodeN/A
Related LinksN/A